Fall 2023 issue of quarterly NFID eNewsletter covering:
- NFID National Survey: Attitudes about Respiratory Diseases
- 2023 Annual News Conference
- Online Clinical Vaccinology Course
- 50th Anniversary Gala Recap
- NFID Resources (Videos, Webinars, Podcasts, Blogs)
- More …
Message From Headquarters
For the first time ever, vaccines and preventive monoclonal antibodies are available to help protect against 3 major respiratory viruses: influenza (flu), COVID-19, and respiratory syncytial virus (RSV). Despite that good news, data from a new National Foundation for Infectious Diseases (NFID) survey of US adults found that fewer than 1 in 4 US adults are concerned about getting infected with these viruses, and 43% do not plan to, or are unsure if they will get vaccinated against flu. Only 40% plan to get an updated COVID-19 vaccine, and only 40% of adults age 60 years and older plan to get vaccinated against RSV …
